1. Home
  2. CNTA vs BUR Comparison

CNTA vs BUR Comparison

Compare CNTA & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • BUR
  • Stock Information
  • Founded
  • CNTA 2020
  • BUR 2009
  • Country
  • CNTA United Kingdom
  • BUR Guernsey
  • Employees
  • CNTA N/A
  • BUR N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • BUR Finance: Consumer Services
  • Sector
  • CNTA Health Care
  • BUR Finance
  • Exchange
  • CNTA Nasdaq
  • BUR Nasdaq
  • Market Cap
  • CNTA 2.3B
  • BUR 2.8B
  • IPO Year
  • CNTA 2021
  • BUR 2010
  • Fundamental
  • Price
  • CNTA $22.52
  • BUR $9.47
  • Analyst Decision
  • CNTA Strong Buy
  • BUR Buy
  • Analyst Count
  • CNTA 9
  • BUR 1
  • Target Price
  • CNTA $31.75
  • BUR $18.00
  • AVG Volume (30 Days)
  • CNTA 859.3K
  • BUR 2.4M
  • Earning Date
  • CNTA 11-12-2025
  • BUR 11-05-2025
  • Dividend Yield
  • CNTA N/A
  • BUR 1.32%
  • EPS Growth
  • CNTA N/A
  • BUR N/A
  • EPS
  • CNTA N/A
  • BUR 1.08
  • Revenue
  • CNTA $15,000,000.00
  • BUR $443,251,000.00
  • Revenue This Year
  • CNTA N/A
  • BUR $17.08
  • Revenue Next Year
  • CNTA N/A
  • BUR $9.43
  • P/E Ratio
  • CNTA N/A
  • BUR $8.77
  • Revenue Growth
  • CNTA 118.88
  • BUR N/A
  • 52 Week Low
  • CNTA $9.60
  • BUR $9.31
  • 52 Week High
  • CNTA $25.42
  • BUR $15.73
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 45.18
  • BUR 29.51
  • Support Level
  • CNTA $23.45
  • BUR $9.38
  • Resistance Level
  • CNTA $25.35
  • BUR $10.05
  • Average True Range (ATR)
  • CNTA 1.37
  • BUR 0.41
  • MACD
  • CNTA -0.17
  • BUR -0.08
  • Stochastic Oscillator
  • CNTA 65.90
  • BUR 16.26

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About BUR Burford Capital Limited

Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.

Share on Social Networks: